FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly, the use of human lactoferrin apo-form as an antihypoxant and a hypoxia inducible factor-1 alpha stabiliser.
EFFECT: invention provides the use of the natural iron chelator lactoferrin, no toxicity, hypoallergenicity, an ability to penetrate through the bowel into the blood flow and through the blood-brain barrier.
2 tbl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTING HYPOXIA | 2003 |
|
RU2251432C2 |
3-(N,N-DIMETHYLCARBAMOYLHYDROXY)-2-ETHYL-6-METHYLPYRIDINE SUCCINATE SHOWING ANTIHYPOXIC ACTIVITY | 1993 |
|
RU2095350C1 |
METHOD FOR INCREASING BODY RESISTANCE TO ACUTE HYPOXIA IN EXPERIMENT | 2013 |
|
RU2517032C1 |
PREPARATIONS OF ANTIHYPOXIC PROPERTIES | 2002 |
|
RU2232576C2 |
ANTIHYPOXIC AGENT | 2001 |
|
RU2213571C2 |
METHOD OF ADAPTATION OF ANIMAL BODY TO CHRONIC HYPOBARIC HYPOXIA IN EXPERIMENT | 2022 |
|
RU2800891C1 |
AGENT FOR TREATING BODY IRON OVERLOAD, OR HAEMOCHROMATOSIS | 2014 |
|
RU2557959C1 |
ANTIHYPOXIC AGENT | 2011 |
|
RU2472503C1 |
METHOD FOR TREATING POSTOPERATIVE COMPLICATIONS | 2001 |
|
RU2199337C1 |
ANTIHYPOXANT AND METHOD FOR PREPARING IT | 2013 |
|
RU2506074C1 |
Authors
Dates
2012-10-27—Published
2011-03-11—Filed